Donald R. Conklin
Corporate Officer/Principal en Endoceutics, Inc. .
Perfil
Donald R.
Conklin is currently a Principal at Endoceutics, Inc. He was previously Chairman at Bayer Consumer Care Holdings LLC, Director at Tamir Biotechnology, Inc., Director at Ventiv Health, Inc., Director at CytoTherapuetics, Inc., Director at inVentiv Health, Inc., Executive Vice President at Schering-Plough Corp., and President at Schering Corp.
He holds an MBA from Rutgers State University of New Jersey and an undergraduate degree from Williams College.
Cargos activos de Donald R. Conklin
Empresas | Cargo | Inicio |
---|---|---|
Endoceutics, Inc.
Endoceutics, Inc. Pharmaceuticals: MajorHealth Technology EndoCeutics, Inc. develops hormone therapies. It offers products for vulvovaginal atrophy-sexual dysfunction, treatment of hot flushes and loss of bone, breast cancer treatment, treatment of endometriosis, treatment of prostate cancer, and male hypogonadism. The company was founded on July 26, 2006 and is headquartered in Quebec, Canada. | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Donald R. Conklin.
Empresas | Cargo | Fin |
---|---|---|
Tamir Biotechnology, Inc.
Tamir Biotechnology, Inc. Medical SpecialtiesHealth Technology Tamir Biotechnology, Inc. engages in the discovering and developing of new class therapeutic drugs for the treatment of cancer and other pathological conditions. The firm's proprietary drug discovery program is also the basis for the development of recombinant designed RNases for chemical conjugation and fusion products with various targeting moieties, such as monoclonal antibodies, growth factors, and cytokines. The company was founded on August 24, 1981 and is headquartered in Short Hills, NJ. | Director/Miembro de la Junta | 02/01/2010 |
inVentiv Health, Inc.
inVentiv Health, Inc. Miscellaneous Commercial ServicesCommercial Services inVentiv Health, Inc. provides outsourced product development and commercialization services. It operates its business through the following segments: Clinical and Commercial. The Clinical segment clinical offers a continuum of services spanning phases I-IV of clinical development to the changing needs of pharmaceutical, biotechnology, diagnostic and medical device clients. The Commercial segment consists of selling solution services, communications, patient outcomes and consulting service offerings. The company was founded in 1999 and is headquartered in Burlington, MA. | Director/Miembro de la Junta | 12/06/2007 |
Ventiv Health, Inc. | Director/Miembro de la Junta | 19/06/2006 |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Corporate Officer/Principal | 01/05/1997 |
Schering-Plough Pharmaceuticals | Presidente | 01/01/1994 |
Formación de Donald R. Conklin.
Williams College | Undergraduate Degree |
Rutgers State University of New Jersey | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 9 |
---|---|
Ventiv Health, Inc. | Commercial Services |
Tamir Biotechnology, Inc.
Tamir Biotechnology, Inc. Medical SpecialtiesHealth Technology Tamir Biotechnology, Inc. engages in the discovering and developing of new class therapeutic drugs for the treatment of cancer and other pathological conditions. The firm's proprietary drug discovery program is also the basis for the development of recombinant designed RNases for chemical conjugation and fusion products with various targeting moieties, such as monoclonal antibodies, growth factors, and cytokines. The company was founded on August 24, 1981 and is headquartered in Short Hills, NJ. | Health Technology |
Endoceutics, Inc.
Endoceutics, Inc. Pharmaceuticals: MajorHealth Technology EndoCeutics, Inc. develops hormone therapies. It offers products for vulvovaginal atrophy-sexual dysfunction, treatment of hot flushes and loss of bone, breast cancer treatment, treatment of endometriosis, treatment of prostate cancer, and male hypogonadism. The company was founded on July 26, 2006 and is headquartered in Quebec, Canada. | Health Technology |
inVentiv Health, Inc.
inVentiv Health, Inc. Miscellaneous Commercial ServicesCommercial Services inVentiv Health, Inc. provides outsourced product development and commercialization services. It operates its business through the following segments: Clinical and Commercial. The Clinical segment clinical offers a continuum of services spanning phases I-IV of clinical development to the changing needs of pharmaceutical, biotechnology, diagnostic and medical device clients. The Commercial segment consists of selling solution services, communications, patient outcomes and consulting service offerings. The company was founded in 1999 and is headquartered in Burlington, MA. | Commercial Services |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Health Technology |
Schering Corp.
Schering Corp. Pharmaceuticals: MajorHealth Technology Schering Corp. manufactures pharmaceutical products. It offers products in the areas of allergy and respiratory, anti-infectives, foot care, hepatitis, skin disorders, and sun care. It is a subsidiary of Schering-Plough Corp. The company is headquartered in Kenilworth, NY. | Health Technology |
Schering-Plough Pharmaceuticals | |
Bayer Consumer Care Holdings LLC | |
CytoTherapuetics, Inc. | Finance |
- Bolsa de valores
- Insiders
- Donald R. Conklin